BiotechTube
Home/4D Path/Nicholas Bero, JD
NB

Nicholas Bero, JD

Chief Operating Officer & Chief Legal Officer

4D Path

Therapeutic Areas

Oncology

4D Path Pipeline

DrugIndicationPhase
QPOR Platform for Breast CancerBreast CancerBreakthrough Device Designation
QPOR Platform for Immunotherapy ResponseAdvanced Metastatic MelanomaClinical Study

Leadership Team at 4D Path

JL
Jacopo Leonardi
Chief Executive Officer
SM
Satabhisa Mukhopadhyay, PhD
Founder, Chief Scientific Officer
TD
Tathagata Dasgupta, PhD
Founder, President & Chief Technology Officer
AB
Anna Berry, MD
Consultant Pathologist
View full 4D Path profile